Evaluation of TACE as a therapeutic agent in prostatic carcinoma.
D000728:Androgens / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms
D000728:Androgens
ANDROGENS/therapeutic use; PROSTATE/neoplasms